Halozyme Therapeutics (HALO) had the highest return between July 1, 2006 and December 31, 2006 by a mid-cap US stock, returning 200.4%.
Halozyme Therapeutics (HALO) had the highest return between July 1, 2006 and December 31, 2006 by a mid-cap US stock, returning 200.4%.
Mid-cap stocks are treated as having a market cap between $2B and $10B.